Used primarily in the management of bone-related disorders, this compound is effective in treating hypercalcemia associated with cancer by reducing elevated calcium levels in the blood. It is also utilized to prevent skeletal complications in patients with bone metastases, such as fractures or the need for radiation therapy. In addition, it helps slow bone loss in conditions like Paget's disease, where abnormal bone remodeling occurs. The chemical works by inhibiting osteoclast-mediated bone resorption, thereby maintaining bone integrity and reducing pain associated with bone degradation. It is commonly administered intravenously in clinical settings for patients requiring rapid or sustained intervention in severe bone metabolic conditions.